U.S Class(es): 021, 023, 026, 036, 038
Class Status: Active
First Use: Oct-22-2019
First Use in Commerce: Oct-22-2019
Name | Laurence Rickles |
---|---|
Address | TEVA PHARMACEUTICALS USA, INC. 4oo Interpace Parkway Parsippany, NJ 07054 |
Date | Description | Action Tags | Code |
---|---|---|---|
Sep-11-2017 | NEW APPLICATION ENTERED IN TRAM | NWAPI | |
Sep-13-2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | NWOSI | |
Dec-12-2017 | ASSIGNED TO EXAMINER | DOCKD | |
Dec-12-2017 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAP | |
Dec-27-2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Jan-16-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
Jan-16-2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Mar-13-2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | NOAME | |
Sep-12-2018 | TEAS EXTENSION RECEIVED | EEXTI | |
Sep-12-2018 | EXTENSION 1 FILED | EXT1S | |
Sep-12-2018 | EXTENSION 1 GRANTED | EX1GS | |
Sep-14-2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Mar-07-2019 | TEAS EXTENSION RECEIVED | EEXTI | |
Mar-07-2019 | EXTENSION 2 FILED | EXT2S | |
Mar-07-2019 | EXTENSION 2 GRANTED | EX2GS | |
Mar-09-2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Aug-13-2019 | TEAS EXTENSION RECEIVED | EEXTI | |
Aug-13-2019 | EXTENSION 3 FILED | EXT3S | |
Aug-13-2019 | EXTENSION 3 GRANTED | EX3GS | |
Aug-15-2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | EXRAE | |
Oct-31-2019 | TEAS STATEMENT OF USE RECEIVED | EISUI | |
Nov-13-2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | AITUA | |
Oct-31-2019 | USE AMENDMENT FILED | IUAFS | |
Nov-13-2019 | STATEMENT OF USE PROCESSING COMPLETE | SUPCI | |
Dec-09-2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | CNPRP | |
Dec-10-2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | SUNAE | |
Jan-14-2020 | REGISTERED-PRINCIPAL REGISTER | R.PRA |